Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,178
Out of 5,165 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $27.30 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $75.15 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $224.66 | +42.44% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $88.24 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $30.44 | +57.69% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $175.40 | - | 4 | Apr 16, 2019 | |
| HSDT Solana Company | Downgrades: Neutral | n/a | $2.19 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Holdings | Upgrades: Buy | $80 | $113.77 | -29.68% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $8.24 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $103.85 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $109.95 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $69.79 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $66.34 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $83.56 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $27.30
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $75.15
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $224.66
Upside: +42.44%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $88.24
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $30.44
Upside: +57.69%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $175.40
Upside: -
Solana Company
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $2.19
Upside: -
iRhythm Holdings
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $113.77
Upside: -29.68%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $8.24
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $103.85
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $109.95
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $69.79
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $66.34
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $83.56
Upside: -